InSphero is attending EUROTOX 2026
Join us at EUROTOX 2026 in Vienna, Austria, where the global toxicology community will come together to exchange scientific advances, explore emerging approaches, and shape the future of safety assessment.
We’re looking forward to connecting with researchers across the field and sharing how human-relevant 3D in vitro models can provide deeper, organ-specific insights into drug safety. Our toxicology platforms span liver, gastrointestinal, neuro, and pancreatic models, supporting more physiologically relevant approaches to investigating toxicity and generating meaningful data earlier in development.
By combining advanced 3D biology with scalable, reproducible workflows, these models are designed to help researchers better understand organ-specific responses and translate complex biology into actionable safety insights.
Explore all our activities taking place during EUROTOX 2026 from Sunday, September 13th to Wednesday, September 16th in Vienna. See you there!
Meet our Team at EUROTOX 2026
Bruno Filippi, PhD
Bruno Filippi, PhD
Vice President, Liver Safety
Wolfgang Moritz, PhD
Wolfgang Moritz, PhD
Head of External Collaborations, Co-founder
Bärbel Ulmer, PhD
Bärbel Ulmer, PhD
Director of Business Development
Our Booth at EUROTOX 2026
Visit our booth #8 and discover our physiological, reproducible, and scalable 3D in vitro safety models designed to support more predictive insights for drug development.
Posters at EUROTOX 2026
Enabling Early Safety Assessment with Low-Input RNA-Seq in Liver Microtissues Across Species and Compound Analogs
Date: Tuesday, September 15, 2026 | 9:30 am
Poster Number: P30-32
Abstract Number: 1330
Bruno Filippi, PhD
Bruno Filippi, PhD
Vice President, Liver Safety
MASLD increases sensitivity to chlorpromazine- and trovafloxacin-induced toxicity in a 3D InSight™ human liver spheroid model
Date: Monday, September 14, 2026 | 9:30 am
Poster Number: P19-01
Abstract Number: 991
Bärbel Ulmer, PhD
Bärbel Ulmer, PhD
Director of Business Development
Drug-induced gastrointestinal toxicity assessment – the human small intestinal organoid assay for drug testing
Date: Monday, September 14, 2026 | 9:30 am
Poster Number: P16-06
Abstract Number: 1298
Visit the Tecan booth #16 to see high throughput organoid imaging in the Gri3D® plate!
Toward patient-relevant DILI testing: Integrating intrinsic liver vulnerability with systemic metabolic cues
Date: Monday, September 14, 2026 | 9:30 am
Poster Number: P19-02
Abstract Number: 1004
Wolfgang Moritz, PhD
Wolfgang Moritz, PhD
Head of External Collaborations, Co-founder
Collaborative Posters at EUROTOX 2026
An integrative in silico framework for derisking drug-induced liver injury (DILI) liabilities
Authors: D. Lopez Rodriguez, J. Overman, C. Adessi, M. Correa Marrero, M. Marchesi, R. Matheis, F. Boess, B. G.H. Filippi, B. Ulmer, S. Hauri, J. Keemink, K. Umehara, S. Kustermann, T. Y. Doktorova
Date: Monday, September 14, 2026 | 9:30 am
Poster Number: P18-24
Abstract Number: 858